Diagonal Therapeutics
Focus: Diagonal Therapeutics is a biotechnology company specializing in agonist antibodies, operating at scale with 5000+ employees from its Watertown, MA headquarters. The company is in Series B stage, positioning it as an emerging player in the antibody therapeutics space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Employees
5000+
Total Funding
$128M
Open Jobs
0
About Diagonal Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Diagonal Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
H-1B (2023): 1 approval
Visa Sponsorship
Sponsors Work Visas
Help build intelligence for Diagonal Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.